MAPT and Alzheimer disease: Selenium (Se) is an essential trace element with strong antioxidant capacity in vivo, and various Se compounds have shown positive effects in AD mice, manifested mainly by mitigation of tau pathology, restoration of synaptic deficits and amelioration of cognitive decline through the regulation of autophagic pathway and synaptic receptors [8,9,10].